Exubera hmm… not good

This article was sent to me by my fellow blogger, Ben who suggested that this might be an interesting article for readers. Seems so:

Pfizer Inc and said on Wednesday clinical trials of the inhaled insulin Exubera found increased cases of lung cancer, leading Nektar to stop seeking a marketing partner for the troubled product and abandon it.

I had hopes for Exubera. Did you?

 

Coffee and Diabetes Type 2

I was in the doctor’s office the other day and happened to pic up an article that said something along the of men who drink more than 6 or 8 cups of coffee per day reduce their risk of contracting type 2. As an avid coffee drinker and apologist, I find that comforting. Question: does anyone have info about this study, perhaps you know the name or have an article? Anything would be appreciated. I want to know more about this.

Home Delivery: 3 Good Reasons

The DiabeticSeniors.com site, a resource for mostly general articles to educate elderly on the basics of Type 2 and some Type 1 stuff, has a bit about the three main reasons one would benefit from home delivery of diabetic supplies. I am undecided about making posts with numbers in the title, but the case for consistency, convenience and proximity of diabetic supplies made here is pretty compelling if you want to have a look and comment.

Stabilize Your Blood Sugar

I just found an article in Readers Digest (RD.Com) of all places entitled Stabilize Your Blood Sugar: An Epidemic. It’s nice to hear this preached from a mainstream source instead of the usual diabetes activist types we all seem to be

Whether you already have diabetes, or are overweight, or just want to prevent future health problems, here are 20 ways to make sure your blood sugar and insulin levels are as healthy as can be.

SugarStats Interview

TechAddress has an interview with SugarStats‘ Marston Alfred. SugarStats is an online application that makes it easy to  manage, monitor and share your blood sugar glucose levels online for better control of diabetes from anywhere.